Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |